Listed

LifeMD, Inc.: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on May 24, 2017 and accepted by EDGAR at May 23, 2017, 20:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-01-01 to 2016-12-31$5.2mus-gaap:Revenues
Cost of revenue12 months2016-01-01 to 2016-12-31$1.9mus-gaap:CostOfRevenue
Gross profit12 months2016-01-01 to 2016-12-31$3.3mus-gaap:GrossProfit
Operating income12 months2016-01-01 to 2016-12-31−$1.2mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-01-01 to 2016-12-31$48.6kus-gaap:InterestExpense
Net income12 months2016-01-01 to 2016-12-31−$1.1mus-gaap:NetIncomeLoss
Diluted shares (weighted)12 months2016-01-01 to 2016-12-3133,478,229 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2016-01-01 to 2016-12-31−$407.9kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2016-12-31$182.6kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$789.8kus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$789.8kus-gaap:Assets
Current liabilitiesAt period end2016-12-31$1.2mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2016-12-31−$355.2kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-17-005790. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.